On Tuesday, Procept BioRobotics Corp (NASDAQ: PRCT) opened lower -1.22% from the last session, before settling in for the closing price of $72.99. Price fluctuations for PRCT have ranged from $24.83 to $85.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 142.74% over the last five years. Company’s average yearly earnings per share was noted 15.90% at the time writing. With a float of $48.95 million, this company’s outstanding shares have now reached $50.77 million.
The firm has a total of 626 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.27%, operating margin of -62.09%, and the pretax margin is -58.73%.
Procept BioRobotics Corp (PRCT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Procept BioRobotics Corp is 5.74%, while institutional ownership is 84.78%. The most recent insider transaction that took place on Sep 16 ’24, was worth 2,062,679. In this transaction EVP, CFO of this company sold 25,000 shares at a rate of $82.51, taking the stock ownership to the 96,096 shares. Before that another transaction happened on Sep 16 ’24, when Company’s Affiliate proposed sale 50,000 for $81.11, making the entire transaction worth $4,055,500.
Procept BioRobotics Corp (PRCT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 15.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.10% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Check out the current performance indicators for Procept BioRobotics Corp (PRCT). In the past quarter, the stock posted a quick ratio of 6.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.06, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Analysing the last 5-days average volume posted by the [Procept BioRobotics Corp, PRCT], we can find that recorded value of 0.65 million was better than the volume posted last year of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 37.92%. Additionally, its Average True Range was 3.31.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 56.87%, which indicates a significant increase from 22.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.22% in the past 14 days, which was lower than the 57.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $74.57, while its 200-day Moving Average is $60.22. Now, the first resistance to watch is $73.55. This is followed by the second major resistance level at $74.99. The third major resistance level sits at $76.03. If the price goes on to break the first support level at $71.07, it is likely to go to the next support level at $70.03. Now, if the price goes above the second support level, the third support stands at $68.59.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
There are currently 51,424K shares outstanding in the company with a market cap of 3.74 billion. Presently, the company’s annual sales total 136,190 K according to its annual income of -105,900 K. Last quarter, the company’s sales amounted to 53,350 K and its income totaled -25,630 K.
